Bloomberg on MSN15h
Merck’s $8 Billion Cancer Vaccine Faces First US Jury TrialMerck racked up more than $8 billion in Gardasil sales in 2023 ... vaccine victims to a law firm that is spearheading the Gardasil litigation. As the founder of the nonprofit Children’s Health Defense ...
Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus ...
The suit alleges defendants issued false statements concerning Merck business and prospects, resulting in its stock trading at inflated prices.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback